GSK
Collegeville, PA, USA
Site Name: UK – London – New Oxford Street, UK - Hertfordshire - Stevenage, USA - Massachusetts - Waltham, USA - Pennsylvania - Upper Providence Posted Date: Jan 19 2026 Company Overview At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. GSK enters 2026 with strong momentum, building on 2025 growth and advancing a robust pipeline. We expect key regulatory milestones, including new approvals and expanded indications, supported by 15 pivotal trials. By uniting...


